- $9.33bn
- $9.67bn
- $5.00bn
- 91
- 55
- 91
- 94
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.39 | ||
| PEG Ratio (f) | 0.74 | ||
| EPS Growth (f) | 18.07% | ||
| Dividend Yield (f) | 2.04% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.69 | ||
| Price to Tang. Book | 23.48 | ||
| Price to Free Cashflow | 16.71 | ||
| Price to Sales | 1.92 | ||
| EV to EBITDA | 11.56 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.1% | ||
| Return on Equity | 13.86% | ||
| Operating Margin | 13.21% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4,169.04 | 4,288.64 | 4,576.7 | 4,887.55 | 5,004.99 | 4,518.85 | 4,716.2 | 4.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.84 | +3.24 | +14.25 | +14.23 | +4.31 | +33.82 | +8.46 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Amdocs Limited is a provider of software and services to communications and media companies in both developed countries and emerging markets. The Company's offerings are based on a product and service mix, using technologies and methodologies, such as the cloud and cloud native, microservices, development and operations (DevOps), low-code/no-code, edge computing, open source, bimodal operations, Site Reliability Engineering (SRE) and increasing amounts of automation through standard information technology (IT) tools, open Application programming interface (APIs) and artificial intelligence (AI), generative artificial intelligence (GenAI), and machine learning (ML). Its comprehensive line of services is designed to address every stage of a service provider's lifecycle and includes consulting, delivery, quality engineering (testing), systems integration, operations, network services, experience-driven services, data, cloud, and content services.
Directors
- Robert Minicucci NEC (69)
- Shuky Sheffer PRE (61)
- Tamar Rapaport-Dagim CFO (50)
- Rajat Raheja CEX (51)
- Matthew Smith DIR (49)
- Sarah Davis DRC (54)
- Eliahu Gelman DRC (63)
- Yvette Kanouff DRC (56)
- Giora Yaron DRC (73)
- Rafael de la Vega IND (70)
- Adrian Gardner IND (59)
- James Kahan IND (74)
- Richard LeFave IND (69)
- John MacDonald IND (68)
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 28th, 1988
- Public Since
- June 19th, 1998
- No. of Shareholders
- 3,572
- No. of Employees
- 29,058
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 112,163,000
- Address
- 625 Maryville Centre Drive, Suite 200, SAINT LOUIS, 63141
- Web
- https://www.amdocs.com/
- Phone
- +1 3142127000
- Contact
- Matthew Smith
- Auditors
- Ernst & Young LLP
Upcoming Events for DOX
Q2 2025 Amdocs Ltd Earnings Call
Amdocs Ltd at Needham Technology, Media & Consumer Conference
Amdocs Ltd at JPMorgan Global Technology, Media and Communications Conference
Amdocs Ltd at TD Cowen Technology, Media & Telecom Conference
Amdocs Ltd at Jefferies Software & Internet Conference
Amdocs Ltd at Stifel Boston Cross Sector 1x1 Conference
Amdocs Ltd at Bank of America Global Technology Conference
Amdocs Ltd at UBS Women in Tech Conference
Amdocs Ltd at Mizuho Technology Conference
Amdocs Ltd at Jefferies & Nasdaq Technology Conference
Q3 2025 Amdocs Ltd Earnings Release
FAQ
What is the Amdocs share price?
As of Today at 19:13 UTC, shares in Amdocs are trading at $83.18. This share price information is delayed by 15 minutes.
How has the Amdocs share price performed this year?
Shares in Amdocs last closed at $83.18 and the price had moved by -2.06% over the past 365 days. In terms of relative price strength the Amdocs share price has underperformed the S&P500 Index by -7.91% over the past year.
What are the analyst and broker recommendations for Amdocs?
The overall consensus recommendation for Amdocs is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Amdocs dividend yield?
The Amdocs dividend yield is 2.25% based on the trailing twelve month period.
Does Amdocs pay a dividend?
Last year, Amdocs paid a total dividend of $1.87, and it currently has a trailing dividend yield of 2.25%.Looking ahead, the next dividend pay date is 2025-04-25.
When does Amdocs next pay dividends?
We do not have data on when Amdocs is to next pay dividends. The historic dividend yield on Amdocs shares is currently 2.25%.
How do I buy Amdocs shares?
To buy shares in Amdocs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Amdocs?
As of the previous close price of $83.18, shares in Amdocs had a market capitalisation of $9.33bn.
Where are Amdocs shares listed?
Here are the trading details for Amdocs:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: DOX
What kind of share is Amdocs?
Based on an overall assessment of its quality, value and momentum Amdocs is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Amdocs share price forecast for 2025?
The analyst consensus target price for shares in Amdocs is $101.61. That is 22.16% above the last closing price of $83.18.
Analysts covering Amdocs currently have a consensus Earnings Per Share (EPS) forecast of $6.98 for the next financial year.
Find out moreWhat is the trend in the Amdocs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amdocs. Over the past six months, its share price has outperformed the S&P500 Index by +1.3%.
As of the last closing price of $83.18, shares in Amdocs were trading -3.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Amdocs PE Ratio?
The Amdocs PE ratio based on its reported earnings over the past 12 months is 11.39. The shares last closed at $83.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Amdocs?
Amdocs' management team is headed by:
- Robert Minicucci - NEC
- Shuky Sheffer - PRE
- Tamar Rapaport-Dagim - CFO
- Rajat Raheja - CEX
- Matthew Smith - DIR
- Sarah Davis - DRC
- Eliahu Gelman - DRC
- Yvette Kanouff - DRC
- Giora Yaron - DRC
- Rafael de la Vega - IND
- Adrian Gardner - IND
- James Kahan - IND
- Richard LeFave - IND
- John MacDonald - IND